细胞因子水平在重症乙型肝炎患者表面抗原清除中的临床意义初探

向小梅; 万星; 张娟; 肖剑梅; 王昊亮; 谷冬晴; 邓国宏

doi:10.16016/j.2097-0927.202401009

您当前的位置：

首页 >

文章列表页 >

细胞因子水平在重症乙型肝炎患者表面抗原清除中的临床意义初探

临床医学 | 更新时间：2026-01-09

- 细胞因子水平在重症乙型肝炎患者表面抗原清除中的临床意义初探
- Clinical significance of cytokine levels in HBsAg sero-clearance in patients with severe hepatitis B
- 陆军军医大学学报 2024年46卷第16期页码：1913-1919
- 作者机构：
  
  400038 重庆，陆军军医大学(第三军医大学)第一附属医院感染病科，病毒传染病精准防治重庆市重点实验室
- 作者简介：
  
  [ 邓国宏，E-mail：gdeng@tmmu.edu.cn DENG Guohong, E-mail: gdeng@tmmu.edu.cn
- 基金信息：
  
  国家自然科学基金重点项目(81930061)
- DOI：10.16016/j.2097-0927.202401009
  中图分类号： R392.11;R446.112;R512.62
- 收稿：2024-01-03，
  
  修回：2024-01-17，
  
  纸质出版：2024-08-30
- 稿件说明：
移动端阅览
向小梅, 万星, 张娟, 等. 细胞因子水平在重症乙型肝炎患者表面抗原清除中的临床意义初探[J]. 陆军军医大学学报, 2024,46(16):1913-1919.

Xiaomei XIANG, Xing WAN, Juan ZHANG, et al. Clinical significance of cytokine levels in HBsAg sero-clearance in patients with severe hepatitis B[J]. Journal of Army Medical University, 2024, 46(16): 1913-1919.
向小梅, 万星, 张娟, 等. 细胞因子水平在重症乙型肝炎患者表面抗原清除中的临床意义初探[J]. 陆军军医大学学报, 2024,46(16):1913-1919. DOI： 10.16016/j.2097-0927.202401009.

Xiaomei XIANG, Xing WAN, Juan ZHANG, et al. Clinical significance of cytokine levels in HBsAg sero-clearance in patients with severe hepatitis B[J]. Journal of Army Medical University, 2024, 46(16): 1913-1919. DOI： 10.16016/j.2097-0927.202401009.

摘要

目的

探讨细胞因子的表达在重症乙型肝炎患者表面抗原(hepatitis B surface antigen，HBsAg)清除中是否具有临床意义。

方法

采用巢氏病例-对照研究设计，纳入2006-2020年陆军军医大学第一附属医院感染病科住院的14例重症乙型肝炎患者作为研究对象，其中7例在肝炎活化1年内HBsAg发生清除(HBsAg清除组)，年龄(36.57±3.15)岁；7例在1年内HBsAg下降少于1个lg(HBsAg未清除组)，年龄(34.14±2.97)岁。采用Luminex液相芯片技术检测14例重症乙型肝炎患者入院时血清样本中IFN-γ、IL-2等48种细胞因子表达水平。

结果

HBsAg清除组中3种细胞因子(IFN-γ、IL-2Ra、SDF-1α)表达水平显著低于HBsAg未清除组(

0.05)，其余39种细胞因子表达水平在2组间差异无统计学意义，另5种未在2组间同时表达。血清HBV DNA水平与HGF(

=0.675，

=0.008)及SDF-1α(

=0.587，

=0.027)表达水平呈正相关；与IP-10(

=-0.600，

=0.023)及MIG(

=-0.640，

=0.014)表达水平呈负相关。HBsAg滴度与IL-12p70表达水平呈正相关(

=0.593，

=0.025)，与TNF-α表达水平呈负相关(

=-0.609，

=0.021)。血清总胆红素水平与SCGF-β表达水平呈正相关(

=0.543，

=0.045)。

结论

本研究找到3种差异表达细胞因子及一些与HBV DNA水平、HBsAg滴度相关的细胞因子，可为肝炎活化引起HBV病毒清除的免疫学机制研究提供新思路。同时，为重症乙型肝炎患者HBsAg血清学清除提供潜在标志物。

Abstract

Objective

To explore the clinical significance of serum cytokine expression in the hepatitis B surface antigen (HBsAg) sero-clearance in patients with severe hepatitis B.

Methods

A nested case-control trial was conducted on 14 inpatients with severe hepatitis B admitted in our hospital from 2006 to 2020. Of them

7 patients (aged 36.57±3.15 years) achieved HBsAg sero-clearance within 1 year after the onset of hepatitis B flares (with abrupt rise of ALT level to >5 times the upper limit of normal during HBV infection) and were assigned into HBsAg clearance group

while the other 7 patients (aged 34.14±2.97 years) only obtained HBsAg decreased less than 1 g within 1 year after the onset (HBsAg non-clearance group). Then

multiplex liquid-chip assay based on Luminex xMAP was used to detect the expression levels of 48 cytokines such as IFN-γ and IL-2 in serum samples of these 14 patients.

Results

The serum levels IFN-γ

IL-2Ra and SDF-1α were signif

icantly lower in the HBsAg clearance group than the HBsAg non-clearance group (

0.05)

but no statistical differences were observed in other 39 cytokines between the 2 groups. And there were 5 cytokines having no mutual expression in both groups. The copy number of HBV DNA was positively correlated with serum HGF (

=0.675

=0.008) and SDF-1α levels (

=0.587

=0.027)

while negatively with IP-10 (

=-0.600

=0.023) and MIG level (

=-0.640

=0.014). Meanwhile

a positive correlation was found between HBsAg titer and IL12-p70 level (

=0.593

=0.025)

and a negative correlation between HBsAg titer and TNF-α level (

=-0.609

=0.021). In addition

the serum total bilirubin level was positively correlated with the expression of SCGF-β (

=0.543

=0.045).

Conclusion

Three differentially expressed cytokines and some cytokines related to HBV DNA level and HBsAg titer are found

which may provide new insights into the underlying immunological mechanism of HBV virus clearance caused by hepatitis flares. Meanwhile

it also provides potential biomarkers for HBsAg serological clearance in patients with severe hepatitis B.

关键词

Keywords

references

JENG W J, PAPATHEODORIDIS G V, LOK A S F. Hepatitis B[J]. Lancet, 2023, 401(10381): 1039-1052. DOI: 10.1016/s0140-6736(22)01468-4.

ZHOU K, CONTAG C, WHITAKER E, et al . Spontaneous loss of surface antigen among adults living with chronic hepatitis B virus infection: a systematic review and pooled meta-analyses[J ] . Lancet Gastroenterol Hepatol, 2019, 4(3): 227-238. DOI: 10.1016/s2468-1253(18)30308-x.

CHANG M L, LIAW Y F. Hepatitis B flares in chronic hepatitis B: pathogenesis, natural course, and management[J]. J Hepatol, 2014, 61(6): 1407-1417. DOI: 10.1016/j.jhep.2014.08.033.

GHANY M G, FELD J J, CHANG K M, et al . Serum alanine aminotransferase flares in chronic hepatitis B infection: the good and the bad[J ] . Lancet Gastroenterol Hepatol, 2020, 5(4): 406-417. DOI: 10.1016/s2468-1253(19)30344-9.

KIM G A, LIM Y S, AN J, et al . HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durability[J ] . Gut, 2014, 63(8): 1325-1332. DOI: 10.1136/gutjnl-2013-305517.

PERRILLO R P. Acute flares in chronic hepatitis B: the natural and unnatural history of an immunologically mediated liver disease[J]. Gastroenterology, 2001, 120(4): 1009-1022. DOI: 10.1053/gast.2001.22461.

顾琳琳, 胡瑞, 窦宇明, 等. 聚乙二醇干扰素α-2b治疗HBeAg阴性慢性乙型肝炎实现临床治愈的预测因素分析[J]. 肝脏, 2023, 28(3): 313-319. DOI: 10.14000/j.cnki.issn.1008-1704.2023.03.014.

GU L L, HU R, DOU Y M, et al . Predictors associated with functional cure in HBeAg-negative chronic hepatitis B patients treated with pegylated interferon α-2b[J ] . Chin Hepatol, 2023, 28(3): 313-319. DOI: 10.14000/j.cnki.issn.1008-1704.2023.03.014.

中华医学会感染病学分会, 中华医学会肝病学分会. 慢性乙型肝炎临床治愈(功能性治愈)专家共识[J]. 中华肝脏病杂志, 2019, 27(8): 594-603. DOI: 10.3760/cma.j.issn.1007-3418.2019.08.003.

Chinese Society of Infectious Disease of Chinese Medical Association, Chinese Society of Hepatology of Chinese Medical Association. The expert consensus on clinical cure (functional cure) of chronic hepatitis B[J]. Chin J Hepatol, 2019, 27(8): 594-603. DOI: 10.3760/cma.j.issn.1007-3418.2019.08.003.

SONNEVELD M J, CHIU S M, PARK J Y, et al . Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels[J ] . J Hepatol, 2022, 76(5): 1042-1050. DOI: 10.1016/j.jhep.2022.01.007.

ZOUTENDIJK R, HANSEN B E, VAN VUUREN A J, et al . Serum HBsAg decline during long-term potent nucleos(t)ide analogue therapy for chronic hepatitis B and prediction of HBsAg loss[J ] . J Infect Dis, 2011, 204(3): 415-418. DOI: 10.1093/infdis/jir282.

SHEEN I S, LIAW Y F, TAI D I, et al . Hepatic decompensation associated with hepatitis B e antigen clearance in chronic type B hepatitis[J ] . Gastroenterology, 1985, 89(4): 732-735. DOI: 10.1016/0016-5085(85)90566-9.

唐洁婷, 房静远, 顾伟齐. 乙肝肝硬化患者血清IFN-γ及相关因子水平与肝脏炎症活动的关系[J]. 世界华人消化杂志, 2004, 12(4): 1002-1004. DOI: 10.3969/j.issn.1009-3079.2004.04.066.

TANG J T, FANG J Y, GU W Q. Relation between level of IFN-gamma and activity of liver inflammation in patients with hepatitis B virus-related cirrhosis[J]. World Chin J Digestol, 2004, 12(4): 1002-1004. DOI: 10.3969/j.issn.1009-3079.2004.04.066.

MA Z, LIU J, WU W, et al . The IL-1R/TLR signaling pathway is essential for efficient CD8 + T-cell responses against hepatitis B virus in the hydrodynamic injection mouse model[J ] . Cell Mol Immunol, 2017, 14(12): 997-1008. DOI: 10.1038/cmi.2017.43..

王昊亮, 邓国宏. 慢性HBV感染者病毒特异性T淋巴细胞: 耗竭还是沉默?[J]. 临床肝胆病杂志, 2020, 36(5): 980-982. DOI: 10.3969/j.issn.1001-5256.2020.05.005.

WANG H L, DENG G H. Functional status of hepatitis B virus -specific T cells in patients with chronic hepatitis B virus infection: Exhausted or silenced?[J]. J Clin Hepatol, 2020, 36(5): 980-982. DOI: 10.3969/j.issn.1001-5256.2020.05.005.

王庆国, 严福华, 徐鹏举, 等. 四氯化碳诱导的小鼠肝纤维化模型中SDF-1α/CXCR4的表达及其意义[J]. 中国实验动物学报, 2009, 17(5): 384-387. DOI: 10.3969/j.issn.1005-4847.2009.05.015.

WANG Q G, YAN F H, XUE P J, et al . Expression of stromal cell-derived factor 1α(SDF-1α) and CXC chemokine receptor 4 (CXCR4) and their significance in CCl4-induced liver fibrosis in mice[J ] . Acta Laboratorium Animalis Scientia Sinica, 2009, 17(5): 384-387. DOI: 10.3969/j.issn.1005-4847.2009.05.015.

KANEKO T, MURAKAMIT, KAWANA H, et al . Sphingosine-1-phosphate receptor agonists suppress concanavalin A-induced he patic injury in mice[J ] . Biochem Biophys Res Commun, 2006, 345(1): 85-92. DOI: 10.1016/j.bbrc.2006.04.067.

OZDEN M, KALKAN A, DEMIRDAG K, et al . Hepatocyte growth factor (HGF) in patients with hepatitis B and meningitis[J ] . J Infect, 2004, 49(3): 229-235. DOI: 10.1016/j.jinf.2003.12.001.

FABIANIS. Hepatitis B virus infection and interferon-inducible protein-10[J]. Clin Ter, 2015, 166(3): e188-e196. DOI: 10.7417/ct.2015.1853.

WU J, HAN M, LI J, et al . Immunopathogenesis of HBV infection[J ] . Adv Exp Med Biol, 2020, 1179: 71-107. DOI: 10.1007/978-981-13-9151-4_4.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

重庆市交通相关PM2.5短期大剂量暴露对大鼠肺部炎症的影响

PQ401的体内外抗炎效应研究

两种干细胞对颅脑创伤炎症反应调控作用的对比研究

调节性T细胞在肝再生增强因子免疫抑制机制中的作用研究

三氮脒减轻内毒素诱导性小鼠葡萄膜炎的研究